foxhunt/DQN_HYPEROPT_FINAL_RESULTS.md

DQN Hyperopt Final Results - CRITICAL ANALYSIS REQUIRED

Date: 2025-11-02 Pod ID: aryszyyzz3flzo Status: ⚠️ RESULTS REQUIRE VALIDATION BEFORE PRODUCTION Expert Review: CRITICAL ISSUES IDENTIFIED

---

Executive Summary

DQN hyperopt completed 22 trials in 26.9 minutes, costing $0.11 (RTX A4000 @ $0.25/hr). The best trial (#17) achieved an objective of 0.000575 with learning rate 9.29e-4. However, CRITICAL VALIDATION ISSUES have been identified by expert analysis that must be resolved before production deployment.

Key Metrics

• Total Trials: 22/50 (44% completion, early stopping likely triggered)
• Training Duration: 26.9 minutes (21:08:19 to 21:35:11)
• Cost: $0.11 USD
• Success Rate: 100% (no failed trials)
• Average Trial Time: 73.3 seconds

---

⚠️ CRITICAL ISSUES IDENTIFIED (MUST RESOLVE)

Issue #1: Validation Loss Anomaly - SEVERE RED FLAG

Problem: Trial #17 shows validation loss (12,297) that is 240x lower than training loss (3,055,089).

Why This is Wrong:

• Healthy models should have val_loss close to or slightly higher than train_loss
• A 240x difference indicates one of the following critical bugs:
  1. Data Leakage: Validation set contaminating training process
  2. Incorrect Validation Logic: Bugged val_loss calculation or wrong metric
  3. Non-representative Data: Poor train/val split

Expert Assessment:

"This is a classic symptom of data leakage or incorrect validation logic. A validation loss drastically lower than training loss suggests a flaw in evaluation methodology, not a well-generalized model."

Required Actions:

1. ✅ Review train/val split logic in /home/jgrusewski/Work/foxhunt/ml/src/trainers/dqn.rs
2. ✅ Audit loss calculation code - confirm both use same metric
3. ✅ Verify sample counts - are they evaluated over comparable batches?
4. ✅ Test with fresh data split to reproduce results
5. ✅ Add validation logging to confirm data separation

File to Investigate: /home/jgrusewski/Work/foxhunt/ml/src/trainers/dqn.rs (lines 976+)

---

Issue #2: Known Critical Bugs in Hyperopt Adapter

Problem: Previous analysis identified 3 CRITICAL bugs in the DQN hyperopt adapter that would cause guaranteed failures:

1. Path Validation Inconsistency (CRITICAL)

   • Constructor validates dbn_data_dir as directory (lines 246-251)
   • Runtime checks if it's a file (lines 647-652)
   • Mutually exclusive logic guarantees failure
   • File: /home/jgrusewski/Work/foxhunt/ml/src/hyperopt/adapters/dqn.rs

2. Unimplemented DBN Fallback (CRITICAL)

   • DBN loading fallback returns explicit error (lines 478-482)
   • Guaranteed panic when parquet detection fails
   • File: /home/jgrusewski/Work/foxhunt/ml/src/hyperopt/adapters/dqn.rs

3. Parameter Mismatch (HIGH)

   • train_from_parquet expects file path
   • Adapter passes directory path
   • File: /home/jgrusewski/Work/foxhunt/ml/src/hyperopt/adapters/dqn.rs (lines 664-686)

Expert Question:

"What is the status of these fixes? Deploying a service with a known, guaranteed panic path is unacceptable."

Required Actions:

1. ⏳ Verify if these bugs were fixed before this hyperopt run
2. ⏳ If not fixed, explain how hyperopt succeeded (different code path?)
3. ⏳ Provide commit hashes or PR links for bug fixes
4. ⏳ Re-run tests to confirm fixes are stable

---

Issue #3: Early Stopping Without Explanation

Problem: Hyperopt stopped at 22/50 trials (44% completion) with no error messages in logs.

Possible Causes:

• Manual termination
• Pod timeout
• Early stopping criteria triggered (but not logged)
• RunPod infrastructure issue

Expert Concern:

"Understanding why training stopped early is crucial. Was it algorithmic success (convergence) or infrastructure failure?"

Required Actions:

1. ✅ Check RunPod pod logs for termination reason
2. ✅ Review early stopping configuration in hyperopt adapter
3. ✅ Verify if objective values plateaued (justifying early stop)
4. ✅ Document stopping criteria for future runs

---

📊 Hyperopt Results Analysis

Top 5 Best Hyperparameters

Rank	Trial	Objective	LR	Batch	Gamma	Eps Decay	Buffer	Train Loss	Val Loss	Q-Value	Time (s)
1	#17	0.000575	9.29e-4	198	0.9614	0.9946	137,745	3,055,089	12,297 ⚠️	381.85	33.73
2	#16	0.000328	4.36e-4	215	0.9701	0.9922	883,835	1,984,814	165,661	507.53	60.05
3	#12	0.000137	1.27e-5	192	0.9878	0.9920	223,580	2,783,271	438,186	703.11	66.14
4	#4	0.000119	1.61e-5	147	0.9851	0.9950	160,309	2,185,002	314,176	628.93	76.19
5	#10	0.000098	2.10e-5	193	0.9736	0.9912	31,651	2,687,526	332,359	695.68	66.47

⚠️ WARNING: Trial #17's validation loss is 240x lower than training loss - requires investigation

---

Learning Rate Analysis

Observation: Top trials show two distinct learning rate regimes:

• High LR regime: 4.36e-4 to 9.29e-4 (Trials #16, #17)
• Low LR regime: 1.27e-5 to 2.10e-5 (Trials #4, #10, #12)

Comparison with PPO:

• PPO best: policy_lr = 1.0e-6, value_lr = 1.0e-3
• DQN best: lr = 9.29e-4 (single LR)
• DQN tolerates 1000x higher LR than PPO's policy network

Expert Caution:

"A learning rate of 9.29e-4 is high. Run 3-5 trials with different random seeds to ensure Trial #17 wasn't an outlier."

Required Validation:

1. ⏳ Re-run Trial #17 hyperparameters with 3-5 different seeds
2. ⏳ Confirm performance consistency across seeds
3. ⏳ Monitor for training instability (divergence, NaN/Inf)

---

Batch Size Correlation

Finding: Top 5 trials all use large batches (147-215)

• Best trial: 198 (sweet spot)
• Smaller batches (<100) consistently underperform

Interpretation: DQN benefits from larger batch sizes for stable Q-value estimation.

---

Gamma (Discount Factor) Analysis

Range: 0.9614 to 0.9878 across top 5 trials

• Higher gamma values (>0.97) appear in 4/5 top trials
• Suggests DQN benefits from long-term planning horizon

---

🔍 Comparison with PPO Hyperopt

Metric	DQN	PPO	Ratio
Trials Completed	22	63	0.35x
Duration (min)	26.9	14.3	1.88x
Cost (USD)	$0.11	$0.06	1.83x
Avg Trial Time (s)	73.3	13.6	5.4x
Best LR	9.29e-4	1.0e-6 (policy)	929x
Target Completion	44%	126%	0.35x

Key Insights:

• DQN trials are 5.4x slower than PPO (more complex Q-network updates)
• DQN early-stopped at 44% completion (22/50 trials)
• PPO exceeded target (63/50 trials, 126%)
• DQN tolerates 929x higher learning rates than PPO's policy network

---

📋 Recommended Next Steps (PRIORITY ORDER)

Priority 1: Validation Loss Investigation (CRITICAL - BLOCKS DEPLOYMENT)

Estimated Time: 2-4 hours Owner: ML Team Tasks:

1. Review train/val split logic in ml/src/trainers/dqn.rs
2. Audit loss calculation code - confirm both use same metric
3. Add debug logging to print sample counts and loss computation
4. Re-run Trial #17 with fixed validation to confirm results
5. Document findings in separate bug report

Acceptance Criteria:

• Val loss is within 0.5-2x of train loss (healthy range)
• OR clear explanation of why 240x difference is correct
• Code review confirms no data leakage or metric bugs

---

Priority 2: Critical Bug Status Verification (CRITICAL - BLOCKS DEPLOYMENT)

Estimated Time: 1-2 hours Owner: Engineering Team Tasks:

1. Verify if path validation bugs were fixed before hyperopt run
2. Provide commit hashes or PR links for fixes
3. Run integration tests to confirm stability
4. Update CLAUDE.md with fix status

Acceptance Criteria:

• All 3 critical bugs fixed and merged
• Tests pass with both file and directory paths
• No panics in error scenarios

---

Priority 3: Multi-Seed Validation (HIGH - REQUIRED FOR PRODUCTION)

Estimated Time: 2-3 hours Owner: ML Team Tasks:

1. Re-run Trial #17 hyperparameters with 5 different seeds
2. Compare objective values across seeds (expect <10% variance)
3. Monitor for training instability (NaN/Inf, divergence)
4. Document variance and select most stable configuration

Acceptance Criteria:

• Objective values within ±10% across seeds
• No NaN/Inf errors
• Consistent convergence behavior

---

Priority 4: Full Production Training (PENDING VALIDATION)

Estimated Time: 1-2 hours Owner: ML Team Prerequisites: Priorities 1-3 completed successfully Tasks:

1. Deploy production training with validated hyperparameters
2. Increase epochs from 20 to 100 (full training)
3. Monitor convergence and Q-value stability
4. Save final model to S3

Configuration (use only after validation):

--learning-rate 0.000929
--batch-size 198
--gamma 0.9614
--epsilon-decay 0.9946
--buffer-size 137745
--epochs 100

Acceptance Criteria:

• Model converges without divergence
• Q-values remain stable (±20% range)
• Backtest Sharpe >1.5, Win Rate >55%

---

🚨 Production Deployment Decision: ❌ NOT READY

Expert Assessment:

"I cannot agree with the 'ready for production' assessment. The validation loss discrepancy is the most significant threat to the validity of this entire hyperopt effort."

Blocking Issues:

1. ⚠️ Validation loss anomaly (240x lower than train loss)
2. ⚠️ Critical bugs status unknown
3. ⚠️ Single-seed results (no variance testing)
4. ⚠️ Early stopping without explanation

Required Actions Before Deployment:

• ✅ Resolve validation loss discrepancy
• ✅ Confirm critical bugs are fixed
• ✅ Validate with 3-5 random seeds
• ✅ Re-run hyperopt to 50 trials if needed

---

📁 Downloaded Files

All hyperopt results saved to:

/tmp/dqn_results/
├── training_runs/
│   └── dqn/
│       └── run_20251102_210818_hyperopt/
│           ├── hyperopt/
│           │   └── trials.json (6.6 KB, 22 trials)
│           └── logs/
│               └── training.log (7.5 KB, complete log)

JSON Export:

• /tmp/dqn_best_params.json - Top 5 hyperparameters in structured format

---

🎯 Conclusion

DQN hyperopt successfully completed 22 trials and identified promising hyperparameters. However, critical validation issues prevent immediate production deployment:

1. Validation loss anomaly requires urgent investigation
2. Critical bugs status must be confirmed
3. Multi-seed validation needed for high-LR configuration

Recommended Path Forward:

1. Investigate validation loss calculation (2-4 hours)
2. Verify critical bug fixes (1-2 hours)
3. Run multi-seed validation (2-3 hours)
4. Re-evaluate production readiness (1 hour)

Total Estimated Time to Production: 6-10 hours of validation work

---

Last Updated: 2025-11-02 Status: ⚠️ VALIDATION REQUIRED Next Review: After Priority 1-3 completion